1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RTN4R CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA WDR6 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA UPP1 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA KCNMB2 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA ZNF211 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA EXOSC1 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA RP5-994D16.11 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA ZNF580 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA C19orf24 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA MORN2 CTRPv2 pan-cancer AAC -0.12 0.0006
Download CSV